Showing results (1-10 of 902) with videos related to
Sort By:
Pageof 91
Clinical Science (London, England : 1979)|July 1, 1986
Plasma catecholamines in pregnancy induced hypertensionP C Rubin, L Butters, R McCabe, et al.American Journal of Hypertension|April 1, 1988
Nifedipine and platelets in preeclampsiaP C Rubin, L Butters, R McCabeClinical Science (London, England : 1979)|July 1, 1987
The influence of pregnancy on drug action: concentration-effect modelling with propranololP C Rubin, L Butters, R McCabe, et al.British Journal of Clinical Pharmacology|August 1, 1982
Atenolol in the treatment of essential hypertension during pregnancyP C Rubin, L Butters, R A Low, et al.British Journal of Clinical Pharmacology|November 1, 1983
Clinical pharmacological studies with prazosin during pregnancy complicated by hypertensionP C Rubin, L Butters, R A Low, et al.British Journal of Clinical Pharmacology|April 1, 1983
Labetalol disposition and concentration-effect relationships during pregnancyP C Rubin, L Butters, A W Kelman, et al.British Journal of Obstetrics and Gynaecology|June 1, 1985
Plasma catecholamines and modes of delivery: the relation between catecholamine levels and in-vitro platelet aggregation and adrenoreceptor radioligand binding characteristicsC R Jones, J McCullouch, L Butters, et al.British Journal of Clinical Pharmacology|December 1, 1983
Atenolol elimination in the neonateP C Rubin, L Butters, B Reynolds, et al.BMJ (Clinical Research Ed.)|September 22, 1990
Atenolol in essential hypertension during pregnancyL Butters, S Kennedy, P C RubinAmerican Journal of Obstetrics and Gynecology|October 15, 1984
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenololP C Rubin, L Butters, D Clark, et al.Pageof 91